Preventing a Silent Killer: Decoding the Hepatitis Vaccine Market
Immunization Against Liver Inflammation: An Introduction to the Hepatitis Vaccine Market
The hepatitis vaccine market encompasses vaccines designed to prevent viral hepatitis, primarily hepatitis A and hepatitis B. These vaccines work by stimulating the body's immune system to produce antibodies that provide long-lasting protection against these liver-damaging viruses. Hepatitis A vaccines are typically inactivated viral vaccines, while hepatitis B vaccines are usually recombinant vaccines made using genetic engineering. Vaccination is a cornerstone of public health efforts to control and eventually eliminate hepatitis A and B infections, which can lead to severe liver disease, liver cancer, and death.
Market Drivers and Global Public Health Initiatives
The hepatitis vaccine market is driven by global and national public health initiatives aimed at preventing hepatitis A and B infections. Vaccination programs targeting infants, children, and at-risk adults (e.g., healthcare workers, individuals with chronic liver disease, travelers to endemic areas) are major drivers. The increasing…